1. Role of ARPC2 in Human Gastric Cancer.
   Jun Zhang et al, 2017, Mediators Inflamm CrossRef
2. Nutlin-3 plus tanshinone IIA exhibits synergetic anti-leukemia effect with imatinib by reactivating p53 and inhibiting the AKT/mTOR pathway in Ph+ ALL
   Yong Guo et al, 2017, Biochem. J. CrossRef
3. The antitumor natural product tanshinone IIA inhibits protein kinase C and acts synergistically with 17-AAG
   Chao Lv et al, 2018, Cell Death Dis CrossRef
4. MicroRNA-1231 exerts a tumor suppressor role through regulating the EGFR/PI3K/AKT axis in glioma
   Jiale Zhang et al, 2018, J Neurooncol CrossRef
5. The anticancer mechanism investigation of Tanshinone IIA by pharmacological clustering in protein network
   Yan-feng Cao et al, 2018, BMC Syst Biol CrossRef
6. The combination of Nutlin-3 and Tanshinone IIA promotes synergistic cytotoxicity in acute leukemic cells expressing wild-type p53 by co-regulating MDM2-P53 and the AKT/mTOR pathway
   Yong Guo et al, 2018, The International Journal of Biochemistry & Cell Biology CrossRef
7. Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway.
   Jin Zhou et al, 2020, Cell Prolif CrossRef
8. Phosphoproteome analysis reveals dynamic heat shock protein 27 phosphorylation in tanshinone IIA-induced cell death
   Chieh-Fan Yin et al, 2020, J. Proteome Res. CrossRef
9. The Anticancer Properties of Tanshinones and the Pharmacological Effects of Their Active Ingredients
   Li Fu et al, 2020, Front. Pharmacol. CrossRef
10. An overview of the anti-cancer actions of Tanshinones, derived from Salvia miltiorrhiza (Danshen)
    Irum Naz et al, 2020 CrossRef
11. HB-EGF Activates the EGFR/HIF-1α Pathway to Induce Proliferation of Arsenic-Transformed Cells and Tumor Growth
    Lin Wang et al, 2020, Front. Oncol. CrossRef
12. Tanshinone‑IIA attenuates the deleterious effects of oxidative stress in osteoporosis through the NF‑κB signaling pathway
    Shaowen Zhu et al, 2018, Mol Med Report CrossRef
13. LY294002 inhibits the Warburg effect in gastric cancer cells by downregulating pyruvate kinase M2.
    Jian Lu et al, 2018, Oncol Lett CrossRef
14. Anticancer effect of resibufogenin on gastric carcinoma cells through the phosphoinositide 3-kinase/protein kinase B/glycogen synthase kinase 3β signaling pathway.
    Zhen Lu et al, 2018, Oncol Lett CrossRef
15. Tanshinone IIA regulates human AML cell proliferation, cell cycle, and apoptosis through miR-497-5p/AKT3 axis
    Zi-Yuan Nie et al, 2020, Cancer Cell Int CrossRef
16. Tanshinone IIA mediates SMAD7-YAP interaction to inhibit liver cancer growth by inactivating the transforming growth factor beta signaling pathway
    Lifang Ma et al, 2019, Aging CrossRef
17. Pharmacological basis of tanshinone and new insights into tanshinone as a multitarget natural product for multifaceted diseases
    Zhibei Li et al, 2020, Biomedicine & Pharmacotherapy CrossRef
18. Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation.
    Zhenhua Guan et al, 2020, Biosci Rep CrossRef
19. Tanshinone IIA: A Review of its Anticancer Effects
    Zhong‐ying Fang et al, 2021, Front. Pharmacol. CrossRef
20. Tanshinone IIA inhibits gastric cancer cell stemness through inducing ferroptosis.
    Haiwei Ni et al, 2022, Environ Toxicol CrossRef
21. Recent Research Progress (2015–2021) and Perspectives on the Pharmacological Effects and Mechanisms of Tanshinone IIA
    Chenhui Zhong et al, 2021, Front. Pharmacol. CrossRef
22. Tanshinone IIA potentiates the efficacy of imatinib by regulating the AKT‑MDM2‑P53 signaling pathway in Philadelphia chromosome‑positive acute lymphoblastic leukemia
    Yong Guo et al, 2021, Oncol Lett CrossRef
23. Tanshinone IIA: New Perspective on the Anti-Tumor Mechanism of A Traditional Natural Medicine.
    Wenfeng Zhang et al, 2022, Am J Chin Med CrossRef
24. Molecular Mechanism of Tanshinone against Prostate Cancer
    Wei Li et al, 2022, Molecules CrossRef
25. The Regulatory Effects of Traditional Chinese Medicine on Ferroptosis
    Qian Gao et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
26. MiR-218-5p/EGFR Signaling in Arsenic-Induced Carcinogenesis
    Ranakul Islam et al, 2023, Cancers CrossRef
27. Tanshinone-I for the treatment of uterine fibroids: molecular docking, simulation, and density functional theory investigations
    Abhishek Tiwari et al, 2023, Saudi Pharmaceutical Journal CrossRef
28. Enhanced Sestrin expression through Tanshinone 2A treatment improves PI3K-dependent inhibition of glioma growth
    Judith Schaf et al, 2023, Cell Death Discov. CrossRef
29. Therapeutic Effect of Polaprezinc on Reflux Esophagitis in the Rat Model
    Wenbo Xie et al, 2023, Dig Dis Sci CrossRef
30. Study on the Mechanism of Sanqi in the Treatment of Disseminated Intravascular Coagulation-Based on Network Pharmacology and Molecular Docking Technology
    Xin Yao et al, 2023, LDDD CrossRef
31. The mechanisms of tanshinone in the treatment of tumors.
    Pengyu Zhang et al, 2023, Front Pharmacol CrossRef
32. Tanshinone IIA inhibits proliferation and migration by downregulation of the PI3K/Akt pathway in small cell lung cancer cells
    Yuxin Jiang et al, 2024, BMC Complement Med Ther CrossRef
33. Systematic investigation of Radix Salviae for treating diabetic peripheral neuropathy disease based on network Pharmacology
    Tao Kang et al, 2024, World J Diabetes CrossRef